Literature DB >> 15207308

Smallpox: the basics.

Mark K Slifka1, Jon M Hanifin.   

Abstract

Variola major is the causative agent of smallpox, a severe disease that was arguably one of the most serious human pathogens in recorded history. Humans are the only known reservoir of variola major; no known animal or insect reservoirs have been identified. Thus, after eradication of smallpox through a global immunization effort, this incredibly lethal scourge was eliminated from all corners of the globe. Despite the total eradication of naturally occurring smallpox, there are still stockpiles of smallpox virus maintained in the United States and the former Soviet Union. Unfortunately, it is impossible to know if all smallpox stocks have been accounted for or whether unknown or unreported stocks of smallpox may still exist. In the age of genetic engineering, these viruses could theoretically be modified to increase their virulence to the levels associated with smallpox itself.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207308     DOI: 10.1016/j.det.2004.03.002

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  8 in total

1.  5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity.

Authors:  Xuesen Fan; Xinying Zhang; Longhu Zhou; Kathy A Keith; Earl R Kern; Paul F Torrence
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

Review 2.  Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.

Authors:  Stephen R Walsh; Raphael Dolin
Journal:  Expert Rev Vaccines       Date:  2011-08       Impact factor: 5.217

Review 3.  Imaging viral infection in vivo to gain unique perspectives on cellular antiviral immunity.

Authors:  Sophia M Vrba; Heather D Hickman
Journal:  Immunol Rev       Date:  2021-11-18       Impact factor: 10.983

4.  Low-Temperature Multiple Micro-Dispensing on Microneedles for Accurate Transcutaneous Smallpox Vaccination.

Authors:  Sang-Gu Yim; Yun-Ho Hwang; Seonyeong An; Keum-Yong Seong; Seo-Yeon Kim; Semin Kim; Hyeseon Lee; Kang-Oh Lee; Mi-Young Kim; Dokeun Kim; You-Jin Kim; Seung-Yun Yang
Journal:  Vaccines (Basel)       Date:  2022-04-04

Review 5.  Wanted, dead or alive: new viral vaccines.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

6.  Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium.

Authors:  John P Shannon; Sophia M Vrba; Glennys V Reynoso; Erica Wynne-Jones; Olena Kamenyeva; Courtney S Malo; Christian R Cherry; Daniel T McManus; Heather D Hickman
Journal:  Immunity       Date:  2021-01-11       Impact factor: 31.745

7.  The Future of Smallpox Vaccination: is MVA the key?

Authors:  Mark K Slifka
Journal:  Med Immunol       Date:  2005-03-01

8.  Eczema herpeticum and clinical criteria for investigating smallpox.

Authors:  David A Boyd; Leonard C Sperling; Scott A Norton
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.